Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
75
NCT01562626
Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2012
Completion: May 31, 2021